placeholder newsslider

News in Detail

Publication of Preclinical Efficacy Results on IOP-Lowering Compounds announced

Nicox SA anounces the publication of Preclinical Efficacy Results on a new class of Non-PGA NO-Donating IOP-Lowering Compounds

Nicox SA announced the publication of preclinical IOP-lowering results on a new class of non-prostaglandin analog (PGA), nitric oxide (NO)-donating compounds, in the Journal of Ocular Pharmacology and Therapeutics.